Kilroy Conor 4

What Happened Conor Kilroy, Aura Biosciences' Chief Legal Officer and Secretary, was granted 14,858 restricted stock units (RSUs) on July 1, 2026. The grant price is listed as $0.00, so there was no cash paid by the reporting person; the reported acquisition value is $0. This is an equity award (compensation), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-07-01; Transaction code: A (Award/Grant).
• Shares/units granted: 14,858 RSUs; reported acquisition price: $0.00; reported value: $0.
• Vesting: These RSUs vest in two substantially equal annual installments beginning July 15, 2027, subject to continued service. (Footnote: award under the Issuer's 2021 Stock Option and Incentive Plan; each RSU equals one share.)
• Shares owned after transaction: not disclosed in the provided filing excerpt.
• Filing timeliness: Reported with period and filing date of 2026-07-01 (no late filing indicated).

Context RSUs are a common form of equity compensation that convert into company shares upon vesting; they do not reflect an immediate purchase or sale and therefore are not a direct bullish or bearish trading signal. This grant increases potential future share ownership if Kilroy remains employed through the vesting dates.